This Content Component encountered an error
Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
One of the best tools to help practitioners make the best bedside clinical decisions when managing patients with acute cardiovascular disease.
A comprehensive guidelines implementation toolkit especially for Nurses & Allied Professionals.
Prof. Olov Wiklund
Prof. Ana Abreu
Lowering of LDL-C is one of the main objectives in secondary prevention. Intensive statin treatment and if necessary, combination therapy can reach the treatment goals for most patients. In addition to the drug treatment, the patients should be encouraged to adopt a healthy lifestyle including a diet that improves the lipid profile.
Please visit the webpage Cardioprotective drugs: Statins & more for treatment goal recommendations.
Lifestyle changes should include all aspects of healthy living/a healthy lifestyle
Please visit the webpage Cardioprotective drugs: Statins & more for detailed recommendations.
Please visit the webpage Cardioprotective drugs: Statins & more for information on the Adverse Effects of Statins.
FLOW CHART: dyslipidaemia treatment strategy (1)
Reiner Z, Wiklund O, Betteridge J. Chapter 15 Lipids. In: Gielen S, De Backer G, Piepoli MF, Wood D, editors. The ESC Textbook of Preventive Cardiology. 2nd ed. United Kingdom: Oxford University Press, 2016.
Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Eur Heart J 2016; 37: 2315–2381.
Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J 2016; 37: 2999-3058.
The ESC Prevention of Cardiovascular Disease programme is supported by AMGEN, AstraZeneca, Ferrer, and Sanofi and Regeneron in the form of educational grants.
Watch the webinar recording
This master class was held in June 2016, at the European Heart House.
Take the online course to test your knowledge with MCQs!
Our mission: To reduce the burden of cardiovascular disease.
© 2019 European Society of Cardiology. All rights reserved.